Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
We describe the case of a 24 year old woman, affected by haemorrhagic shock due to post-partum uterine atony, who underwent an emergency hysterectomy with persistent postoperative bleeding, successfully treated with recombinant activated factor VII (Novoseven).
Department of Anaesthesiology and Intensive Care, S. Giovanni di Dio Hospital, Crotone, Italy. marioverre@tiscali.it
M
M
Verre
F
F
Bossio
A
A
Mammone
M
M
Piccirillo
F
F
Tancioni
M
M
Varano
D000328:Adult; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use; D012720:Severity of Illness Index
D011994:Recombinant Proteins; D015942:Factor VIIa